XML 114 R98.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Additional Information to the Items of Profit or Loss (Details) - Schedule of Additional Information to the Items of Profit or Loss - USD ($) $ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020
a. Research and development expenses: |  |  |
Research and development expenses | $ 2,803 | $ 1,990 | $ 649
b. General and administrative expenses: |  |  |
General and administrative expenses | 6,509 | 3,778 | 1,902
c. Other expenses: |  |  |
Other expenses, net | 109 |  | 742
d. Finance income: |  |  |
Net change in fair value of financial liabilities designated at fair value through profit or loss | (7,832) |  | (630)
Finance income | (7,832) |  | (630)
e. Finance expenses: |  |  |
Issuance expenses related to warrants | 1,204 | 6 | 835
Exchange rate differences, net | 4 | 3 | 12
Losses from remeasurement of investment in financial assets | 770 |  |
Finance expense in respect of leases | 15 | 4 | 7
Finance expenses from interest and commissions | 21 | 8 | 18
Finance expenses | 2,014 | 21 | 872
Wages and related expenses [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 436 | 357 | 322
b. General and administrative expenses: |  |  |
General and administrative expenses | 437 | 256 | 237
Share-based payment [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 264 | 27 | 69
b. General and administrative expenses: |  |  |
General and administrative expenses | 633 | 16 | 22
Regulatory, professional and other expenses [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 750 | 934 | 119
Research and preclinical studies [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 703 | 165 | 139
Clinical studies [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 369 | 172 |
Chemistry and formulations [Member] |  |  |
a. Research and development expenses: |  |  |
Research and development expenses | 281 | 335 |
Professional and directors’ fees [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 2,499 | 2,417 | 1,283
Business development expenses [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 161 | 5 | 58
Regulatory expenses [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 162 | 165 | 98
Office maintenance, rent and other expenses [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 224 | 135 | 182
Wellution operating expenses [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 907 |  |
Investor relations and business expenses [Member] |  |  |
b. General and administrative expenses: |  |  |
General and administrative expenses | 1,486 | 784 | 22
Impairment of investment in associate [Member] |  |  |
c. Other expenses: |  |  |
Other expenses, net |  |  | 742
Group’s share of losses of company accounted for at equity, net [Member] |  |  |
c. Other expenses: |  |  |
Other expenses, net | $ 109 |  |

X
- Definition The amount of income or cost associated with interest and other financing activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_FinanceIncomeCost
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The gains (losses) on financial assets at fair value through profit or loss. [Refer: Financial assets at fair value through profit or loss] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 7 -IssueDate 2023-01-01 -Paragraph 20 -Subparagraph a -Clause i -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=7&code=ifrs-tx-2023-en-r&anchor=para_20_a_i&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_GainsLossesOnFinancialAssetsAtFairValueThroughProfitOrLoss
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount that comprises the change in the carrying amount of the group of insurance contracts arising from: (a) the effect of the time value of money and changes in the time value of money; and (b) the effect of financial risk and changes in financial risk; but (c) excluding any such changes for groups of insurance contracts with direct participation features that would adjust the contractual service margin but do not do so when applying paragraphs 45(b)(ii), 45(b)(iii), 45(c)(ii) or 45(c)(iii) of IFRS 17. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 17 -IssueDate 2023-01-01 -Paragraph 110 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=17&code=ifrs-tx-2023-en-r&anchor=para_110&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_InsuranceFinanceIncomeExpenses
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of operating income (expense) that the entity does not separately disclose in the same statement or note. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_OtherOperatingIncomeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expense relating to selling, general and administrative activities of the entity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2023-01-01 -Paragraph 85 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=1&code=ifrs-tx-2023-en-r&anchor=para_85&doctype=Standard -URIDate 2023-03-23 + Details
Name: | ifrs-full_SellingGeneralAndAdministrativeExpense
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_AResearchAndDevelopmentExpensesAbstract0
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_BGeneralAndAdministrativeExpensesAbstract0
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_COtherExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_FinanceExpensesAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expenses related to exchange rate differences. + References No definition available. + Details
Name: | sprcy_FinanceExpensesFromExchangeRateDifferences
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The amount of finance expenses from interest and commissions. + References No definition available. + Details
Name: | sprcy_FinanceExpensesFromInterestAndCommissions
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_FinanceIncomeAbstract
Namespace Prefix: | sprcy_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_FinanceIncomeFromConvertibleLoan
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_InterestExpenseInRespectOfLeases
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- References No definition available. + Details
Name: | sprcy_IssueExpensesRelatedToIssuanceOfWarrants
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. + References No definition available. + Details
Name: | sprcy_ResearchAndDevelopmentExpenses1
Namespace Prefix: | sprcy_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WagesAndRelatedExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ShareBasedPaymentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ResearchAndPreclinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ClinicalStudiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ChemistryAndFormulationsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ProfessionalAndDirectorsFeesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_BusinessDevelopmentExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_RegulatoryExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_OfficeMaintenanceRentAndOtherExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_WellutionOperatingExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_InvestorRelationsAndBusinessExpensesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_ImpairmentOfInvestmentInAssociateMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | sprcy_IncomeStatementsLocationsAxis=sprcy_GroupsShareOfLossesOfCompanyAccountedForAtEquityNetMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |